Back to Search
HOWARD PYO, D.O
D.O
Family Medicine Physician
NPI: 1831540632IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Education
LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE, ERIE
Class of 2016
Research & Publications (20)
TERE; a novel cis-element responsible for a coordinated expression of genes related to programmed cell death and secondary wall formation during differentiation of tracheary elements.
PMID 17683474·Plant J·2007
8-other
Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy.
PMID 15936552·Int J Radiat Oncol Biol Phys·2005
8-other
Multichannel surface plasmon resonance imaging and analysis of micropatterned self-assembled monolayers and protein affinity interactions.
PMID 15620298·Langmuir·2005
8-other
Spatial and temporal tracing of vessel differentiation in young Arabidopsis seedlings by the expression of an immature tracheary element-specific promoter.
PMID 15564536·Plant Cell Physiol·2004
8-other
A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
PMID 11595687·Clin Cancer Res·2001
7-preclinical
Cyclooxygenase-2 (COX-2) negatively regulates expression of epidermal growth factor receptor and causes resistance to gefitinib in COX-2-overexpressing cancer cells.
PMID 19671676·Mol Cancer Res·2009
8-other
Cyclooxygenase-2 up-regulates ataxia telangiectasia and Rad3 related through extracellular signal-regulated kinase activation.
PMID 19584262·Mol Cancer Res·2009
8-other
Escherichia coli expressing single-chain Fv on the cell surface as a potential prophylactic of porcine epidemic diarrhea virus.
PMID 19428826·Vaccine·2009
7-preclinical
Microscopic gold particle-based fiducial markers for proton therapy of prostate cancer.
PMID 19616746·Int J Radiat Oncol Biol Phys·2009
8-other
A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
PMID 19117690·Int J Radiat Oncol Biol Phys·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 2000 E CHAPMAN AVE
FULLERTON, CA 92831 - Phone
- (909) 802-0015
Quick Facts
- NPI
- 1831540632
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile